Use of MigraineBoxTM Head and Neck Cooling Bath for Treatment of Primary Headache in the Emergency Department
NCT ID: NCT01977001
Last Updated: 2014-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2012-11-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BrainCool-Migraine Intranasal Cooling Trial
NCT03167060
Transnasal Cooling for Migraine
NCT04936061
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
NCT06051604
Intranasal Cooling for Cluster Headache and Migraine
NCT01898455
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)
NCT04925414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary Headache
Treatment with MigraineBoxTM
MigraineBoxTM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MigraineBoxTM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Benign headache
* Physician intends to treat headache pain in the ED with either droperidol, prochlorperazine, or a parenteral narcotic
Exclusion Criteria
* Headache due to trauma, subarachnoid hemorrhage, meningitis, intracerebral bleed, cranial tumor, sinusitis, dental pathology, temporomandibular joint dysfunction, glaucoma, or systemic infection
* Known renal impairment
* Known hepatic impairment
* A history of coronary artery disease, peripheral vascular disease, or cerebrovascular disease
* Perforated ear drum
* Pregnant
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hennepin Healthcare Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James R Miner, MD
Role: PRINCIPAL_INVESTIGATOR
Hennepin Healthcare Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-3542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.